Diane M. Harper, et al. Gynecologic Oncology, April 2019 – Download the article The publication has been featured in The Lancet Oncology and Medpage Today Publication
Year: 2019
The Enhanced Tumor Specificity of TG6002, an Armed Oncolytic Vaccinia Virus Deleted in Two Genes Involved in Nucleotide Metabolism
Johann Foloppe, et al. Molecular Therapy Oncolytics, March 2019 – Download the article Publication
Transgene and BioInvent Extend their Collaboration to Develop Multifunctional Oncolytic Viruses for the Treatment of Solid Tumors
20190326 PR BioInvent extension CDR US
Transgene: A positive 2018, moving ahead with a strong portfolio
20180320 FY RESULTS EN
Transgene secures a €20 Million Revolving Credit Facility with Natixis
20190318 PR Natixis loan EN
NEOVIVA project supporting the development of myvac® awarded a €5.2 million grant from Bpifrance’s “Investments for the Future” programme
20190313 – Neoviva – EN
2018 Half-Year Results and Business Update
Transgene to start clinical development of lead myvac® individualized immunotherapy, TG4050, in 2019, under its partnership with NEC
20190305-PR-NEC-Agreement-US-1